Quick Answer
LianBio reported Shares Outstanding of 107.04 million shares for fiscal year 2022.
LianBio Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2022 | 107.04M | -0.2% |
| 2021 | 107.28M | +423.9% |
| 2020 | 20.48M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | 107.17M | -1.1% | +0.0% |
| June 30, 2023 | 107.17M | -1.1% | +0.0% |
| March 31, 2023 | 107.16M | -0.1% | +0.1% |
| December 31, 2022 | 107.04M | -0.2% | -1.2% |
| September 30, 2022 | 108.35M | — | +0.0% |
| June 30, 2022 | 108.35M | — | +1.0% |
| March 31, 2022 | 107.28M | — | +0.0% |
| December 31, 2021 | 107.28M | — | — |
- LianBio showed a decrease of -0.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2022 period, LianBio’s shares outstanding has grown by 422.7% (from 20.48 million shares to 107.04 million shares).
- The most recent figure is from LianBio’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 28, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: